University of Toronto - the Hospital For Sick Children (Sickkids)

Toronto, Ontario M5G1X8

1 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumor, CNS Tumor, NonSegmental Vitiligo, Recurrent WHO Grade II Glioma

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo — Recruiting now
• Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations — Withdrawn before enrolling